Preview

Lechaschi Vrach

Advanced search

Biomarkers of gastrointestinal mucosal regeneration in gastric ulcer

https://doi.org/10.51793/OS.2026.29.3.001

Abstract

Background. In modern gastroenterology, ulcerative lesions of the gastrointestinal tract are the subject of increased attention. In the Russian Federation, digestive diseases occupy the 5th-6th place in the general population in terms of prevalence, and the annual incidence of peptic ulcer disease is 0.1-0.3%. Research in this area is focused, among other things, on the search for biomarkers associated with the processes of regeneration of the mucous membrane in ulcerative pathology, due to the fact that the processes of regeneration of the mucous membrane play an important role the role in treatment. Ulcer healing mechanisms such as cell differentiation, proliferation, migration, re-epithelialization, granulation tissue formation, angiogenesis, vasculogenesis, interaction between various cells and the matrix, and tissue remodeling are coordinated by cytokines: tumor necrosis factor, interleukins (IL-1β, IL-6), growth factors (epidermal growth factor, hepatocyte growth factor). Perspectwin sees the study of the possibility of using biomarkers in the diagnosis, control of the course of the disease, the choice of therapies and the prediction of complications.
Objective. To systematize modern data on biomarkers related to the processes of regeneration of the mucous membrane in gastric ulcer, as well as to determine the prospects for their use to improve existing diagnostic and treatment methods. Materials and methods. Within the framework of this scientific article, a comprehensive analysis of the medical literature devoted to the verification and treatment of peptic ulcer pathology was carried out. The research included original scientific papers published over the past 7 years (2018-2025).
Results. The analysis of modern literature data has shown that biomarkers such as specific cytokines and growth factors, markers of inflammation and tissue regeneration are becoming important tools for assessing regenerative processes in the focus of the pathological process. Their role in the pathogenesis of the disease and ensuring regeneration processes emphasizes the importance of determining their level in patient management.
Conclusion. The study of new biomarkers of gastric ulcer contributes to improving the effectiveness and quality of therapy, preventing the occurrence of complications, including carcinogenesis of the ulcerative focus.

About the Authors

V. S. Fedotov
Voronezh State Medical University named after N. N. Burdenko
Russian Federation

Vladislav S. Fedotov, PhD student the Department of polyclinic therapy

10 Studencheskaya str. Voronezh, 394036



O. N. Krasnorutskaya
Voronezh State Medical University named after N. N. Burdenko
Russian Federation

Olga N. Krasnorutskaya, Dr. of Sci. (Med.), Professor, Head of the Department of infectious diseases and clinical immunology

10 Studencheskaya str. Voronezh, 394036



V. A. Melnikova
Voronezh State Medical University named after N. N. Burdenko
Russian Federation

Valeriya A. Melnikova, 6th year student of the Faculty of Medicine, Federal State Budgetary Educational

10 Studencheskaya str. Voronezh, 394036



S. A. Fedorova
Voronezh State Medical University named after N. N. Burdenko
Russian Federation

Sofya A. Fedorova, 6th year student of the Faculty of Medicine

10 Studencheskaya str. Voronezh, 394036



V. I. Shevcova
Voronezh State Medical University named after N. N. Burdenko
Russian Federation

Veroniсa I. Shevсova, Cand. of Sci. (Med.), Associate Professor of the Department of infectious diseases and clinical immunology

10 Studencheskaya str. Voronezh, 394036



References

1. Perehodov S. N., Milyukov V. E., Bartosh N. O., Krasnoperova M. S. Modern assessment of epidemiology and complications of gastric and duodenal peptic ulcer disease. Vestnik Rossiiskogo universiteta druzhby narodov. Seriya: Medicina. 2024; 2 (28): 230-245. (In Russ.)

2. Alexandrova G. A., Golubev N. A., Tyurina E. M., Oskov Yu. I., Shelepova E. A., Polikarpov A. V. Morbidity of the entire population of Russia in 2019 with a diagnosis established for the first time in their lives. Statisticheskie materialy. H. I. M., 2020. 252 р. (In Russ.)

3. Tarasconi A. Coccolini F., Biffl W. L. Perforated and bleeding peptic ulcer: WSES guidelines. World journal of emergency surgery. 2020; 15: 1-24. URL: https://pubmed.ncbi.nlm.nih.gov/31921329/.

4. Sychev D. A., Kantemirova B. I. Modern Biomarkers as Tools for Patient-Centered Medicine: Pharmacogenetics and Beyond. Farmakogenetika i farmakogenomika. 2022; (1): 3-4. (In Russ.)

5. Mayev I. V., Andreev D. N., Kucheryavy Yu. A. Peptic ulcer disease from the perspective of modern medicine: a manual for doctors. Prima Print. Prakticheskaya gastroenterologiya. 2022; 36. (In Russ.)

6. Tarnawski A. S., Ahluwalia A. The Critical Role of Growth Factors in Gastric Ulcer Healing: The Cellular and Molecular Mechanisms and Potential Clinical Implications. Cells. 2021; 10 (8): 1964. URL: https://pubmed.ncbi.nlm.nih.gov/34440733/.

7. Topolyanskaya S. V. Tumor Necrosis Factor-Alpha and Age-Related Pathologies. The Russian Arkhi vnutrennei meditsiny. 2020; 10 (6): 414-421. (In Russ.)

8. Arkhipova A. A., Anischenko V. V. Modern possilbities and prospects of early diagnosis of stomach cancer. Acta biomedica scientifica. 2021; 6 (3): 113-125. (In Russ.)

9. Belkovets A. V., Kurilovich S. A., Maksimov V. N., Scherbakova L. V. Genetic polymorphism of the inflfl ammatory cytokines IL-1β and IL-6 in patients with serologically identififi ed atrophic gastritis. Eksperimentalnaya i klinicheskaya gastroenterologiya. 2020; 182 (10): 25-32. (In Russ.)

10. Mehrabani D., Khajehahmadi Z., Tajik P., Tamadon A., Rahmanifar F., Ashraf M., Tanideh N., Zare S. Regenerative Effect of Bone Marrow-derived Mesenchymal Stem Cells in Thioacetamide-induced Liver Fibrosis of Rats. Arch Razi Inst. 2019; 74 (3): 279-286. URL: https://pubmed.ncbi.nlm.nih.gov/31592593/.

11. Saleh M., Sohrabpour A. A., Mehrabi M. R., Seyhoun I., Vaezi A. A. Therapeutic approach of adipose-derived mesenchymal stem cells in refractory peptic ulcer. Stem Cell Res Ther. 2021 Sep 26; 12 (1): 515. URL: https://pubmed.ncbi.nlm.nih.gov/34565461/.

12. Trukhan D. I., Sulimov A. F., Trukhan L. Yu. recurrent aphthosic stomatitis: rebamipide – a new direction in treatment and prevention. Klinicheskii razbor v obshchei meditsine. 2024; 5 (1): 23-29. (In Russ.)

13. Titov S. E., Anishchenko V. V., Poloz T. L., Veryaskina Yu. A., Arkhipova A. A., Ustinov S. N. Differential diagnostics of gastric cancer and precancerous changes of the gastric mucosa using analysis of expression of six microRNAS. Klinicheskaya laboratornaya diagnostika. 2020; 65 (2): 131-136. (In Russ.)

14. Plebani M. Why C-reactive protein is one of the most requested tests in clinical laboratories? Clin Chem Lab Med. 2023 Feb 6; 61(9): 1540-1545. URL: https://pubmed.ncbi.nlm.nih.gov/36745137/.

15. Utkina E. A., Afanasyeva O. I., Pokrovsky S. N. C-reactive protein: pathogenetic characteristics and possible therapeutic target. Rossiiskii kardiologicheskii zhurnal. 2021; 26 (6): 128-134. (In Russ.)

16. Grigorkevich O. S., Mokrov G. V, Kosova L. Yu. Matrix metalloproteinases and their inhibitors. Farmakokinetika i farmakodinamika. 2019; 2: 3-16. (In Russ.)

17. Samoylova E. V., Chepurnova D. A., Fesenko A. G., Korotaeva A. A. Regulation of meprin metalloproteinase activity as a way to influence regenerative processes. Geny i kletki. 2022. 17 (3): 203-204. (In Russ.)

18. Rashid Z. A., Bardaweel S. K. Novel Matrix Metalloproteinase-9 (MMP-9) Inhibitors in Cancer Treatment. Int J Mol Sci. 2023; 24 (15): 12133. URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC10418771/.

19. Vasilev S. A., Gorgidze L. A., Efremov E. E., Belinin G. Yu., Moiseeva T. N., Al-Radi L. S., Sokolova M. A., Guria G. T., Zozulya N. I., Kokhno A. V. Fibronectin: structure, functions, clinical significance (review). Aterotromboz. 2022; 12 (1): 138-158. (In Russ.)

20. Osipova T. V., Bukhman V. M. Biomarkers of translational medicine. Rossiiskii bioterapevticheskii zhurnal. 2018; 17 (1): 6-13. (In Russ.)

21. Islamov R. D. Diagnostic features of ulcerative lesions of the stomach and duodenum. Ekonomika and sotsium. 2023; 5-2 (108): 709-714. (In Russ.)

22. Panin S. I., Suvorov V. A., Bikov A. V., Kovalenko N. V., Postolov M. P., Bublikov A. E., Mikhin E. S., Linchenko A. A. Prognostic role of comorbid status in estimation of surgical treatment results in patients with perforated ulcer. Vestnik khirurgii imeni I. I. Grekova. 2022; 181 (3): 20-27. (In Russ.)

23. Uspensky Yu. P., Baryshnikova N. V., Fominykh Yu. A., Ivanov S. V., Gnutov A. A., Gulunov Z. Kh., Sousova Ya. V., Krasnov A. A., Apryatina V. A., Petlenko S. V. The eff ectiveness of the innovative drug "Regasthym Gastro" (alpha-glutamyl tryptophan) in the complex treatment of chronic atrophic gastritis. Eksperimentalnaya i klinicheskaya gastroenterologiya. 2023; 216 (8): 100-102. (In Russ.)

24. Jonaitis P., Kiudelis V., Streleckiene G., Gedgaudas R., Skieceviciene J., Kupcinskas J. Novel Biomarkers in the Diagnosis of Benign and Malignant Gastrointestinal Diseases. Dig Dis. 2022; 40 (1): 1-13. URL: https://pubmed.ncbi.nlm.nih.gov/33647906/.

25. Uspenskiy Yu. P., Baryshnikova N. V., Krasnov A. A., Petlenko S. V., Apryatina V. A. Topical issues of prevention of stomach cancer. Consilium Medicum. 2022; 24 (5): 358-364. (In Russ.)


Review

For citations:


Fedotov V.S., Krasnorutskaya O.N., Melnikova V.A., Fedorova S.A., Shevcova V.I. Biomarkers of gastrointestinal mucosal regeneration in gastric ulcer. Lechaschi Vrach. 2026;(3):10-15. (In Russ.) https://doi.org/10.51793/OS.2026.29.3.001

Views: 179

JATS XML

ISSN 1560-5175 (Print)
ISSN 2687-1181 (Online)